CLN-0046: Treatment of AMD Subjects With OTX-TKI
Clinical trial NCT03630315 · COMPLETED
Trial details
- NCT number
- NCT03630315
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-18
- Primary completion
- 2024-01-10
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.